Evidence map›Paper›PMID 35692578›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Improvement of Biosynthetic Ansamitocin P-3 Production Based on Oxygen-Vector Screening and Metabonomics Analysis.

Xiaolin Zhu, Kaiyao Hou, Peiyang Zheng, Wenya Zhong, Jing Guo, Xiyue Zhao, Tingting Hong, Zhiqiang Cai

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xiaolin ZhuLaboratory of Applied Microbiology and Enzyme Engineering, School of Pharmacy, Changzhou University, Changzhou 213164, Jiangsu, China.
Kaiyao HouWuxi Big Bridge Academy, Wuxi 214115, Jiangsu, China.
Peiyang ZhengLaboratory of Applied Microbiology and Enzyme Engineering, School of Pharmacy, Changzhou University, Changzhou 213164, Jiangsu, China.
Wenya ZhongLaboratory of Applied Microbiology and Enzyme Engineering, School of Pharmacy, Changzhou University, Changzhou 213164, Jiangsu, China.
Jing GuoLaboratory of Applied Microbiology and Enzyme Engineering, School of Pharmacy, Changzhou University, Changzhou 213164, Jiangsu, China.
Xiyue ZhaoLaboratory of Applied Microbiology and Enzyme Engineering, School of Pharmacy, Changzhou University, Changzhou 213164, Jiangsu, China.
Tingting HongLaboratory of Applied Microbiology and Enzyme Engineering, School of Pharmacy, Changzhou University, Changzhou 213164, Jiangsu, China.ORCID https://orcid.org/0000-0002-7604-2974
Zhiqiang CaiLaboratory of Applied Microbiology and Enzyme Engineering, School of Pharmacy, Changzhou University, Changzhou 213164, Jiangsu, China.ORCID https://orcid.org/0000-0002-9180-675X
Changzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel approach involving exogenous oxygen vectors was developed for improving the production of biosynthetic Ansamitocin P-3 (AP-3). Four types of oxygen vectors including soybean oil, n-dodecane, n-hexadecane, and Tween-80 were applied to explore the effect of exogenous oxygen vectors on AP-3 yield. It was observed that soybean oil exhibited a better ability for promoting AP-3 generation than the other three oxygen vectors. Based on the results of the single-factor experiment, response surface methodology was employed to obtain the optimal soybean oil addition method. The optimum soybean oil concentration was 0.52%, and the addition time was 50 h. Under this condition, the yield of AP-3 reached 106.04 mg/L, which was 49.48% higher than that of the control group without adding oxygen vectors. To further investigate the influence of dissolved oxygen on precious orange tufts actinomycetes variety

Identifiers

PMID35692578
PMCPMC9184225
OpenAlexW4281906972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.